Lynn Elsenhans

Lynn Elsenhans (born 1959) is an American businesswoman who has held several high-profile roles in the energy industry. She is best known for her tenure as the CEO and President of Sunoco, a major American petroleum and petrochemical manufacturer, from 2008 to 2012. Elsenhans was the first woman to lead a major oil company.

Early life and education[edit | edit source]

Elsenhans was born in 1959 in Houston, Texas. She earned a Bachelor of Arts degree in Mathematical Sciences from Rice University in 1978, and an MBA from Harvard Business School in 1980.

Career[edit | edit source]

Elsenhans began her career at Royal Dutch Shell, where she worked for more than 28 years in various roles, including Executive Vice President of Global Manufacturing. In 2008, she was appointed as the CEO and President of Sunoco, making her the first woman to lead a major oil company. During her tenure, she led the company through a period of significant restructuring and growth.

In 2012, Elsenhans stepped down from her role at Sunoco and was appointed to the board of directors of Baker Hughes, a leading supplier of oilfield services, products, technology, and systems. She has also served on the boards of several other major corporations, including GlaxoSmithKline and Saudi Aramco.

Recognition[edit | edit source]

Elsenhans has been recognized for her contributions to the energy industry. In 2009, she was named one of the "50 Most Powerful Women in Business" by Fortune Magazine. In 2010, she was included in the list of "100 Most Powerful Women" by Forbes.

Personal life[edit | edit source]

Elsenhans is married and has two children. She is a member of the Rice University Board of Trustees and the American Petroleum Institute.

References[edit | edit source]

This business-related biographical article is a stub. You can help WikiMD by expanding it.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.